Dalvey David 4
4 · Celcuity Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Celcuity Inc.CELC
Dalvey David
Director
Transactions
- Sale
Common Stock
2023-12-08$15.00/sh−5,000$75,000→ 240,000 total(indirect: By Brightstone Venture Capital Fund, LP) - Sale
Common Stock
2023-12-07$14.85/sh−5,000$74,250→ 245,000 total(indirect: By Brightstone Venture Capital Fund, LP)
Holdings
- 11,645
Stock Option (right to buy)
Exercise: $9.58Exp: 2033-05-15→ Common Stock (11,645 underlying) - 9,325
Common Stock
- 5,054
Stock Option (right to buy)
Exercise: $5.50Exp: 2029-05-16→ Common Stock (5,054 underlying) - 2,310
Stock Option (right to buy)
Exercise: $5.50Exp: 2031-05-12→ Common Stock (2,310 underlying) - 24,449
Stock Option (right to buy)
Exercise: $5.50Exp: 2032-05-17→ Common Stock (24,449 underlying) - 8,200
Stock Option (right to buy)
Exercise: $5.50Exp: 2027-10-19→ Common Stock (8,200 underlying) - 3,201
Stock Option (right to buy)
Exercise: $5.50Exp: 2028-05-14→ Common Stock (3,201 underlying) - 12,654
Stock Option (right to buy)
Exercise: $5.10Exp: 2030-05-14→ Common Stock (12,654 underlying)
Footnotes (3)
- [F1]The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP.
- [F2]100% vested.
- [F3]This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.